Table 1.
Inclusion criteria |
---|
Studies in patients with IPF and other ILDs: ILDs including idiopathic conditions (IPF and non-IPF idiopathic interstitial pneumonias), autoimmune-related ILDs, exposure related conditions, chronic sarcoidosis, hypersensitivity pneumonitis and coal workers’ pneumoconiosis |
Studies reporting relevant cough-related outcomes: Humanistic burden of cough – patient reported through use of health-related quality of life instruments or qualitative assessment (focus group/interview series), caregiver health, and caregiver quality of life Economic burden of cough – healthcare resource use, direct and indirect costs, productivity losses |
RCTs with relevant cough-related baseline measurements |
Observational studies including cohort and population-based studies reporting relevant cough-related measures |
Exclusion criteria |
---|
Patients without interstitial lung disease or without cough symptoms |
In vitro studies |
Studies that do not report relevant outcomes |
Studies published prior to 2010 |
Non-English full-text articles |
Non-human studies |
Not containing original data |
Case reports and case series |
Conference abstracts |
Editorials, commentaries, and letters |
ILD: interstitial lung disease; IPF: idiopathic pulmonary fibrosis; RCT: randomised controlled trial